Issue № 1 | 2019 (35)
Results of the assessment of methodological quality of economic evaluations (EE), submitted to justify the inclusion/exclusion of drugs in the lists of drugs for medical use (list of vital and essential drugs, additional medication supply list and expensive drug list), are given in the article. The study was conducted in 2018 in the FSBI “Center for healthcare quality assessment and control” of the Ministry of Health of the Russian Federation. Assessment was performed based on 12 criteria in accordance with the requirements to the methodological quality of economic evaluations, described in the draft Order of the Government of the Russian Federation, No. 871, and then were approved in the Order of the Government of the Russian Federation, No. 871, state on 20.11.2018. The distribution of EE based on the number of criteria they did not meet, and also the frequency of made mistakes for each criterion are presented. Main reasons for EE not meeting the requirements to methodological quality, prescribed by the Order of the Government of the Russian Federation, No. 871, are analyzed.
comprehensive assessment, Order of the Government of the Russian Federation, No. 871, lists of drugs, economic evaluations, methodological quality.
Khachatryan G.R., Ivakhnenko О.I., Sura M.V., Avxentyeva М.V. Assessment of the Methodological Quality of Economic Evaluations: Main Mistakes. Medical Technologies. Assessment and Choice. 2019; 1(35): 8–17.